Short Communication
Lab Coats to Safety Nets: How Artificial Intelligence is Redefining Biosafety Innovations
Authors: Sana Munir, Moiz Ahmed Khan
DOI: https://doi.org/10.37184/jlnh.2959-1805.4.8
Year: 2026
Volume: 4
Received: Jan 08, 2025
Revised: Apr 28, 2025
Accepted: May 07, 2025
Corresponding Auhtor: Moiz Ahmed Khan (moiz_online@yahoo.com)
All articles are published under the Creative Commons Attribution License
ABSTRACT
Artificial intelligence (AI) has radically changed laboratory surveillance and risk perception over the past decade, impacting almost all facets of laboratory safety. AI models combine multiple real-time datasets to predict early outbreaks and alert public health systems. Such models are also used to promptly detect the emergence of hazardous pathogens and heighten safety response. Integration of AI approaches in laboratories enables a smooth flow of automated processes to support specific biohazard-related activities, thereby minimizing human exposure to biohazardous material. In this article, the authors highlight several applications of AI in the successful implementation of a biosafety program, and therefore, in supporting the safety of hospitals and laboratories. However, AI can be harmful in synthetic biology, necessitating the development and enforcement of strict laws. Therefore, it is essential to balance AI-driven innovations with ethical governance to ensure that biosafety laboratories function responsibly.
Keywords: Artificial Intelligence (AI), biosafety, healthcare system, biosurveillance, risk assessment.
INTRODUCTION
Artificial intelligence (AI) can significantly enhance laboratory biosafety by simplifying processes, improving error detection, and enabling more precise data interpretation. By increasingly embracing AI-driven systems, laboratories will be able to automate routine tasks, thereby reducing human error and improving the management of potentially hazardous substances. AI systems can process vast amounts of information to identify patterns indicative of potential safety hazards, enabling real-time monitoring and intervention [1]. Furthermore, AI can help with predictive analysis, aiding laboratories in forecasting and reducing hazards associated with the handling of pathogens or biological experiments. Instead of improving operational safety alone, this integration helps create a culture of proactive risk management in laboratory settings, thereby leading to safer research and diagnostics [1]. Here, the authors aim to explore the potential of AI to enhance several processes related to laboratory biosafety.
EPIDEMIOLOGICAL MODELING AND PATHOGEN PREDICTION
AI-driven models have been vital for predicting disease spread and assessing the effectiveness of public health campaigns. These models have also been employed during the COVID-19 outbreak. By scanning vast datasets, AI can not only predict the emergence of new infections but also mutations in prevalent pathogens. Furthermore, machine-learning algorithms have been instrumental in predicting the risk of zoonotic spillover from animal hosts to humans by means of analyzing viral genome sequences [2].
BIOSURVEILLANCE THROUGH REAL-TIME MONITORING
Early disease outbreak alerts can be provided by AI-based bio-surveillance systems analyzing information from social media, search engine queries, and environmental sensors. In addition, AI can combine and analyze multiple types of data to detect and address unknown hazards. For instance, AI systems are currently being used to predict flu pandemics by analyzing social media patterns and search engine queries [3].
BIOSECURITY AND THREAT DETECTION
In the field of biosecurity, AI can use sophisticated data analytics to enhance biosecurity by detecting potential bio-threats such as unauthorized mutations. Furthermore, synthetic biology techniques could help create genomic constructs with safety protocols to reduce hazards associated with synthetic organisms [4].
LABORATORY SAFETY THROUGH AUTOMATION AND ROBOTICS
AI-powered technologies can reduce human error by enabling AI-driven robots to perform potentially hazardous tasks in high-containment facilities. Furthermore, in BSL-4 settings, AI-controlled robots would minimize hazards to the laboratory personnel in the future by handling hazardous microorganisms [5].
AUDIT AND POLICY-MAKING
AI systems can assist laboratories in improving compliance with biosafety standards and spot potential areas of improvement. Policymakers can use AI to forecast the possible effects of newly introduced policies and assess the efficiency of current biosafety rules [6].
VIRTUAL REALITY AND ADAPTIVE LEARNING
Virtual reality can simulate biosafety scenarios, enabling laboratory workers to practice responding to biosafety risks in a secure, controlled setting. Furthermore, AI could enhance the effectiveness of training programs by tailoring content to each student [7].
CRISIS INTERVENTION, COMMUNICATION AND COORDINATION
In light of the most recent pandemics, AI could help optimize models for biosafety crises through real-time data analysis and more effective resource allocation. As a result, AI can enhance coordination and communication during biosafety events, ensuring information is promptly and effectively transferred [8].
ENVIRONMENTAL MONITORING AND BIOREMEDIATION
AI-driven systems are used in environmental monitoring and bioremediation projects to identify potentially hazardous agents in the environment. For instance, forecasting and managing the expansion of dangerous algal blooms have been accomplished using AI-driven models, with significant implications for public health [9].
PERSONALIZED MEDICINE
AI may revolutionize the management of infectious diseases by generating treatment algorithms tailored to each patient's genetic composition. In addition to curtailing the spread of antimicrobial resistance, individualized strategies can enhance patient outcomes. For instance, by analyzing the patient's genetic profile and the infecting agent, AI models have been used to predict the appropriate antibiotic therapy for the patient [10].
FORECASTING LABORATORY INCIDENTS
AI can forecast potential laboratory accidents by analyzing trends in laboratory procedures and equipment use. Thus, accidents can be addressed beforehand, strengthening the overall safety of the laboratory personnel by a proactive approach. For instance, high-containment labs are using AI-based systems to monitor equipment status and detect early indications of malfunction that could result in safety violations [11].
BIOTERRORISM
Advancements in synthetic biology, along with multimodal AI, may facilitate the production of harmful infectious agents. AI can direct every step of the process, from superbug synthesis to genome selection. To prevent bioterrorism in this regard, stringent regulations on the use of AI in synthetic biology, management of access to genetic information, and careful consideration of the advantages and disadvantages of gain-of-function research are critical [12]. To advance biosafety responsibly, it is imperative to strike a balance between the inventive potential of AI and ethical governance. Enhancing biosecurity, enforcing accountability, regulating AI use, ensuring public scrutiny, conducting audits, and limiting AI use in high-risk situations until safety is demonstrated are all necessary steps to minimize the potentially catastrophic risks of AI advancement [13].
CONCLUSION
AI has the potential to revolutionize biosurveillance, risk assessment, and laboratory safety. While real-time data integration provides early alerts on developing hazards, AI's predictive models help anticipate disease outbreaks and potential pathogen mutations. AI-driven automation in laboratories ensures regulatory compliance while minimizing human exposure to biohazards and optimizing safety precautions by supporting environmental monitoring and bioremediation initiatives. However, the potential for AI misuse in fields such as synthetic biology underscores the need for stringent laws.
CONFLICT OF INTEREST
The authors declare no conflict of interest.
ACKNOWLEDGEMENTS
Declared none.
AUTHORS' CONTRIBUTION
SM - Writing - original draft
MK - Conceptualization and original draft – review and editing.
GENERATIVE AI AND AI-ASSISTED TECHNOLOGIES IN THE WRITING PROCESS
During the preparation of this work, the authors used Perplexity AI to assist with language suggestions, minor proofreading and drafting certain aspects of the article. All AI-assisted content was thoroughly reviewed, edited, and refined by the authors, who take full responsibility for the final content of the published article.
REFERENCES
1. Fan Y-L, Hsu C-H, Wu J-Y, Tsai Y-Y, Chen WJ, Lee M-S, et al. Enhancing safety with an AI-empowered assessment and monitoring system for BSL-3 facilities. Heliyon 2025; 11(1): e40855.
DOI: https://doi.org/10.1016/j.heliyon.2024.e40855 PMID: 39811271
2. Pandit PS, Anthony SJ, Goldstein T, Olival KJ, Doyle MM, Gardner NR, et al. Predicting the potential for zoonotic transmission and host associations for novel viruses. Commun Biol 2022; 5(1): 844.
DOI: https://doi.org/10.1038/s42003-022-03797-9 PMID: 35986178
3. Brownstein JS, Freifeld CC, Madoff LC. Digital disease detection -- harnessing the web for public health surveillance. N Engl J Med 2009; 360(21): 2153-5, 2157.
DOI: https://doi.org/10.1056/nejmp0900702 PMID: 19423867
4. Bloomfield D, Pannu J, Zhu AW, Ng MY, Lewis A, Bendavid E, et al. AI and biosecurity: The need for governance. Science 2024; 385(6711): 831-3.
DOI: https://doi.org/10.1126/science.adq1977 PMID: 39172825
5. Holland I, Davies JA. Automation in the life science research laboratory. Front Bioeng Biotechnol 2020; 8: 571777.
DOI: https://doi.org/10.3389/fbioe.2020.571777 PMID: 33282848
6. Wong F, de la Fuente-Nunez C, Collins JJ. Leveraging artificial intelligence in the fight against infectious diseases. Science 2023; 381(6654): 164-70.
DOI: https://doi.org/10.1126/science.adh1114 PMID: 37440620
7. Tandon I, Maldonado V, Wilkerson M, Walls A, Rao RR, Elsaadany M. Immersive virtual reality-based learning as a supplement for biomedical engineering labs: challenges faced and lessons learned. Front Med Technol 2024; 6: 1301004.
DOI: https://doi.org/10.3389/fmedt.2024.1301004 PMID: 38566843
8. Whitelaw S, Mamas MA, Topol E, Van Spall HGC. Applications of digital technology in COVID-19 pandemic planning and response. Lancet Digit Health 2020; 2(8): e435–40.
DOI: https://doi.org/10.1016/s2589-7500(20)30142-4 PMID: 32835201
9. Adanma UM, Ogunbiyi EO. Artificial intelligence in environmental conservation: evaluating cyber risks and opportunities for sustainable practices. Comput Sci IT Res J 2024; 5(5): 1178-209.
DOI: https://doi.org/10.51594/csitrj.v5i5.1156
10. Johnson KB, Wei W-Q, Weeraratne D, Frisse ME, Misulis K, Rhee K, et al. Precision medicine, AI, and the future of personalized health care. Clin Transl Sci 2021; 14(1): 86-93.
DOI: https://doi.org/10.1111/cts.12884 PMID: 32961010
11. Rojek I, Jasiulewicz-Kaczmarek M, Piechowski M, Mikołajewski D. An artificial intelligence approach for improving maintenance to supervise machine failures and support their repair. Appl Sci (Basel) 2023; 13(8): 4971.
DOI: https://doi.org/10.3390/app13084971
12. Center for AI Safety (CAIF). Biosecurity and AI: Risks and opportunities. Available from: https://www.safe.ai/blog/bios-ecurity-and-ai-risks-and-opportunities [Accessed 2024 Sep 2]
13. Hendrycks D, Mazeika M, Woodside T. An overview of catastrophic AI risks. arXiv 2023. (Preprint) Available from: https://arxiv.org/abs/2306.12001
DOI: http://dx.doi.org/10.48550/ARXIV.2306.12001